AstraZeneca's Camizestrant Shows Positive Interim Results In SERENA-6 Phase 3 Trial
26/2 08:25
(RTTNews) - AstraZeneca plc (AZN, AZN.L), on Wednesday, reported positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial of Of Camizestrant....